|
1
|
Ferlay J, Shin HR, Bray F, Forman D,
Mathers C and Parkin DM: Estimates of worldwide burden of cancer in
2008: GLOBOCAN 2008. Int J Cancer. 127:2893–2917. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Forner A, Hessheimer AJ, Isabel Real M and
Bruix J: Treatment of hepatocellular carcinoma. Crit Rev Oncol
Hematol. 60:89–98. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Jeng KS and Ching HJ: The role of surgery
in the management of unusual complications of transcatheter
arterial embolization for hepatocellular carcinoma. World J Surg.
12:362–368. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bartel DP: MicroRNAs: Target recognition
and regulatory functions. Cell. 136:215–233. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ryan BM, Robles AI and Harris CC: Genetic
variation in microRNA networks: The implications for cancer
research. Nat Rev Cancer. 10:389–402. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ma D, Tao X, Gao F, Fan C and Wu D:
miR-224 functions as an onco-miRNA in hepatocellular carcinoma
cells by activating AKT signaling. Oncol Lett. 4:483–488. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Liu H, Li W, Chen C, Pei Y and Long X:
MiR-335 acts as a potential tumor suppressor miRNA via
downregulating ROCK1 expression in hepatocellular carcinoma. Tumour
Biol. 36:6313–6319. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhang Y, Li T, Guo P, Kang J, Wei Q, Jia
X, Zhao W, Huai W, Qiu Y, Sun L and Han L: MiR-424-5p reversed
epithelial-mesenchymal transition of anchorage-independent HCC
cells by directly targeting ICAT and suppressed HCC progression.
Sci Rep. 4:62482014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Chen J, Wu X, Cai B, Su Z, Li L, An Y and
Wang L: Circulating microRNAs as potential biomarkers of HBV
infection persistence. Infect Genet Evol. 54:152–157. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kenneth J and Livak TD: Analysis of
relative gene expression data using rea l—time
quantitative PCR a nd the 2 □ ct method. Method. 2001.
|
|
11
|
Vitali GC, Laurent A, Terraz S, Majno P,
Buchs NC, Rubbia-Brandt L, Luciani A, Calderaro J, Morel P, Azoulay
D and Toso C: Minimally invasive surgery versus percutaneous radio
frequency ablation for the treatment of single small (</=3 cm)
hepatocellular carcinoma: A case-control study. Surg Endosc.
30:2301–2307. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Xiong W, Sun LP, Chen XM, Li HY, Huang SA
and Jie SH: Comparison of microRNA expression profiles in
HCC-derived microvesicles and the parental cells and evaluation of
their roles in HCC. J Huazhong Univ Sci Technolog Med Sci.
33:346–352. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Deng S, Calin GA, Croce CM, Coukos G and
Zhang L: Mechanisms of microRNA deregulation in human cancer. Cell
Cycle. 7:2643–2646. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Dinkova-Kostova AT, Jenkins SN, Fahey JW,
Ye L, Wehage SL, Liby KT, Stephenson KK, Wade KL and Talalay P:
Protection against UV-light-induced skin carcinogenesis in SKH-1
high-risk mice by sulforaphane-containing broccoli sprout extracts.
Cancer Lett. 240:243–252. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wei CH, Wu G, Cai Q, et al:
MicroRNA-330-3p promotes cell invasion and metastasis in non-small
cell lung cancer through GRIA3 by activating MAPK/ERK signaling
pathway. J Hematol Oncol. 10:1252017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Mao Y, Chen H, Lin Y, Xu X, Hu Z, Zhu Y,
Wu J, Xu X, Zheng X and Xie L: microRNA-330 inhibits cell motility
by downregulating Sp1 in prostate cancer cells. Oncol Rep.
30:327–333. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Huynh H, Nguyen TT, Chow KH, Tan PH, Soo
KC and Tran E: Over-expression of the mitogen-activated protein
kinase (MAPK) kinase (MEK)-MAPK in hepatocellular carcinoma: Its
role in tumor progression and apoptosis. BMC Gastroenterol.
3:192003. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Liang HH, Wei PL, Hung CS, Wu CT, Wang W,
Huang MT and Chang YJ: MicroRNA-200a/b influenced the therapeutic
effects of curcumin in hepatocellular carcinoma (HCC) cells. Tumour
Biol. 34:3209–3218. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Chen X, Zhang L, Zhang T, Hao M, Zhang X,
Zhang J, Xie Q, Wang Y, Guo M, Zhuang H and Lu F:
Methylation-mediated repression of microRNA 129-2 enhances
oncogenic SOX4 expression in HCC. Liver Int. 33:476–486. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhang D, Zhou P, Wang W, Wang X, Li J, Sun
X and Zhang L: MicroRNA-616 promotes the migration, invasion and
epithelial-mesenchymal transition of HCC by targeting PTEN. Oncol
Rep. 35:366–374. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Paiva I, Gil da Costa RM, Ribeiro J, Sousa
H, Bastos MM, Faustino-Rocha A, Lopes C, Oliveira PA and Medeiros
R: MicroRNA-21 expression and susceptibility to HPV-induced
carcinogenesis-role of microenvironment in K14-HPV16 mice model.
Life Sci. 128:8–14. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Paiva I, Gil da Costa RM, Ribeiro J, Sousa
H, Bastos M, Faustino-Rocha A, Lopes C, Oliveira PA and Medeiros R:
A role for microRNA-155 expression in microenvironment associated
to HPV-induced carcinogenesis in K14-HPV16 transgenic mice. PLoS
One. 10:e01168682015. View Article : Google Scholar : PubMed/NCBI
|
